Decreased Gray Matter Concentration and Local Synchronization of Spontaneous Activity in the Motor Cortex in Duchenne Muscular Dystrophy

References

1. 1.↵
   1. Anderson JL,
   2. Head SI,
   3. Rae C,
   4. et al

   . Brain function in Duchenne muscular dystrophy. Brain 2002;125:4–13

   Abstract/FREE Full Text
2. 2.↵
   1. Zubrzycka-Gaarn EE,
   2. Bulman DE,
   3. Karpati G,
   4. et al

   . The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 1988;333:466–69

   CrossRefPubMed
3. 3.↵
   1. Kim TW,
   2. Wu K,
   3. Xu JL,
   4. et al

   . Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 1992;89:11642–44

   Abstract/FREE Full Text
4. 4.↵
   1. Lidov HG,
   2. Byers TJ,
   3. Kunkel LM

   . The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience 1993;54:167–87

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Lidov HG,
   2. Byers TJ,
   3. Watkins SC,
   4. et al

   . Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 1990;348:725–28

   CrossRefPubMed
6. 6.↵
   1. Kim TW,
   2. Wu K,
   3. Black IB

   . Deficiency of brain synaptic dystrophin in human Duchenne muscular dystrophy. Ann Neurol 1995;38:446–49

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Mehler MF

   . Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev 2000;32:277–307

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Carretta D,
   2. Santarelli M,
   3. Vanni D,
   4. et al

   . The organisation of spinal projecting brainstem neurons in an animal model of muscular dystrophy: a retrograde tracing study on mdx mutant mice. Brain Res 2001;895:213–22

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Sbriccoli A,
   2. Santarelli M,
   3. Carretta D,
   4. et al

   . Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse. Neurosci Lett 1995;200:53–56

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Rae C,
    2. Scott RB,
    3. Thompson CH,
    4. et al

    . Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study. J Neurol Sci 1998;160:148–57

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Rae C,
    2. Griffin JL,
    3. Blair DH,
    4. et al

    . Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse. Neuromuscul Disord 2002;12:121–29

    CrossRefPubMed
12. 12.↵
    1. Bresolin N,
    2. Castelli E,
    3. Comi GP,
    4. et al

    . Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul Disord 1994;4:359–69

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Lee JS,
    2. Pfund Z,
    3. Juhasz C,
    4. et al

    . Altered regional brain glucose metabolism in Duchenne muscular dystrophy: a PET study. Muscle Nerve 2002;26:506–12

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Di Lazzaro V,
    2. Restuccia D,
    3. Servidei S,
    4. et al

    . Functional involvement of cerebral cortex in Duchenne muscular dystrophy. Muscle Nerve 1998;21:662–64

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Dunn JF,
    2. Zaim-Wadghiri Y

    . Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 1999;22:1367–71

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Ashburner J,
    2. Friston KJ

    . Voxel-based morphometry: the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Zhang D,
    2. Raichle ME

    . Disease and the brain's dark energy. Nat Rev Neurol 2010;6:15–28

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Logothetis NK,
    2. Pauls J,
    3. Augath M,
    4. et al

    . Neurophysiological investigation of the basis of the fMRI signal. Nature 2001;412:150–57

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Zang Y,
    2. Jiang T,
    3. Lu Y,
    4. et al

    . Regional homogeneity approach to fMRI data analysis. Neuroimage 2004;22:394–400

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Liu H,
    2. Liu Z,
    3. Liang M,
    4. et al

    . Decreased regional homogeneity in schizophrenia: a resting state functional magnetic resonance imaging study. Neuroreport 2006;17:19–22

    CrossRefPubMedWeb of Science
21. 21.↵
    1. He Y,
    2. Wang L,
    3. Zang Y,
    4. et al

    . Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study. Neuroimage 2007;35:488–500

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Cao Q,
    2. Zang Y,
    3. Sun L,
    4. et al

    . Abnormal neural activity in children with attention deficit hyperactivity disorder: a resting-state functional magnetic resonance imaging study. Neuroreport 2006;17:1033–36

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Zhu CZ,
    2. Zang YF,
    3. Cao QJ,
    4. et al

    . Fisher discriminative analysis of resting-state brain function for attention-deficit/hyperactivity disorder. Neuroimage 2008;40:110–20

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Wu T,
    2. Zang Y,
    3. Wang L,
    4. et al

    . Normal aging decreases regional homogeneity of the motor areas in the resting state. Neurosci Lett 2007;423:189–93

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Yuan Y,
    2. Zhang Z,
    3. Bai F,
    4. et al

    . Abnormal neural activity in the patients with remitted geriatric depression: a resting-state functional magnetic resonance imaging study. J Affect Disord 2008;111:145–52

    CrossRefPubMed
26. 26.↵
    1. Wu T,
    2. Long X,
    3. Zang Y,
    4. et al

    . Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp 2009;30:1502–10

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Raichle ME,
    2. MacLeod AM,
    3. Snyder AZ,
    4. et al

    . A default mode of brain function. Proc Natl Acad Sci U S A 2001;98:676–82

    Abstract/FREE Full Text
28. 28.↵
    1. Tzourio-Mazoyer N,
    2. Landeau B,
    3. Papathanassiou D,
    4. et al

    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Cox RW

    . AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162–73

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Talairach J,
    2. Tournoux P

    . Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers; 1988
31. 31.↵
    1. Wright IC,
    2. McGuire PK,
    3. Poline JB,
    4. et al

    . A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage 1995;2:244–52

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Carretta D,
    2. Santarelli M,
    3. Vanni D,
    4. et al

    . Cortical and brainstem neurons containing calcium-binding proteins in a murine model of Duchenne's muscular dystrophy: selective changes in the sensorimotor cortex. J Comp Neurol 2003;456:48–59

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Uchikawa K,
    2. Liu M,
    3. Hanayama K,
    4. et al

    . Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med 2004;36:124–29

    CrossRefPubMed
34. 34.↵
    1. Liepert J,
    2. Schoser BG,
    3. Weiller C

    . Motor excitability in myopathy. Clin Neurophysiol 2004;115:85–89

    CrossRefPubMed
35. 35.↵
    1. Schwenkreis P,
    2. Voigt M,
    3. Hasenbring M,
    4. et al

    . Central mechanisms during fatiguing muscle exercise in muscular dystrophy and fibromyalgia syndrome: a study with transcranial magnetic stimulation. Muscle Nerve 2011;43:479–84

    CrossRefPubMed